Clinical trial · Interventional
A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
Project SUGRI - a Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
NCT06869577CI-TRIAL-00089030SUGRInot yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Feasibility test and evaluation of a group intervention for caregivers to patients diagnosed with a glioblastoma.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Caregiver | — | UNRESOLVED | — |
| Glioblastoma Multiform (Grade IV Astrocytoma) | Glioblastoma | PROBABILISTIC | 0.70 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Project SUGRI: A supportive group intervention for caregivers to patients with a glioblastoma | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- A supportive group intervention
- description
- The intervention consists of following four elements: * Weekly HCP facilitated online group meetings for caregivers (n=12) over three months * Access to a webpage with informational videos of health care professionals and videos with other caregivers * Offer a box of reflection cards and cards to provide caregivers with help * Access to a closed online Facebook group
- interventionNames
- Other: Project SUGRI: A supportive group intervention for caregivers to patients with a glioblastoma
Primary outcomes (2)
- measure
- Feasibility parametres
- timeFrame
- The final evaluation of the feasibility of the intervention will be conducted after the completion of the intervention, which is scheduled to last 12 weeks.
- description
- The primary outcome is the feasibility of the intervention. Accurate feasibility parameters will be outlined when the intervention is fully designed. However, we will most likely access recruitment rate, adherence to the overall intervention, acceptability, and safety. We will establish the final percentages for feasibility within each parameter prior test of the intervention and use these to report the overall feasibility of the intervention. Final percentages will be guided by other feasibility studies within the neuro-oncology field.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Family caregivers (≥18 years) to patients (≥18 years) diagnosed with a GBM grade IV or diffuse astrocytoma grade IV offered Stupps treatment regime. Exclusion Criteria: * Participants who do not understand, read, and speak Danish.
References
Publications (1)
- DERIVEDNordentoft S, Guldager R, Pappot H, Mathiesen T, Tolver A, Piil K. A Supportive Group Intervention for Caregivers to Patients Diagnosed With Glioblastoma: Protocol for the SUGRI Study. JMIR Res Protoc. 2026 Mar 11;15:e81948. doi: 10.2196/81948. PMID 41812182